A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
Clinical trial NCT01396408 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01396408
- Sponsor
- Canadian Cancer Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-09
- Primary completion
- 2015-07-06
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.